Published in TB and Outbreaks Week, June 4th, 2002
Azithromycin is an expensive, broad-spectrum antibiotic; there is limited evidence about its effectiveness in treating bronchitis. Arthur Evans and colleagues from Cook County Hospital, Chicago, Illinois, investigated whether people with bronchitis given azithromycin returned to work earlier, and had greater improvements in health-related quality-of-life scores, compared with individuals given low-dose vitamin C.
The investigators randomly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.